Emerging gene therapy administered through a one-time subretinal injection marks a major milestone for the inherited retinal disease community Initial data expected in Q1 2026 RESEARCH TRIANGLE PARK, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback